Preventing too much immunity

December 27, 2016
Credit: Osaka University

Scientists at the Immunology Frontier Research Center (IFReC), Osaka University, Japan, report a new molecular mechanism that could explain the cause of some autoimmune diseases.

While the immune system is crucial for protecting the body from infection and disease, prolonged activation can damage healthy tissue. After its activation, the immune system is shut off by specialized immune cells known as regulatory T cells (Treg cells). Understanding the development of Treg cells is thought to be critical for combating . "The development of Treg cells in the thymus depends on super-enhancer establishment," explains IFReC Professor Shimon Sakaguchi.

This super-enhancer establishment permits the expression of genes specific for Treg . "Super-enhancers appeared to be a pre-requisite for Treg cell development, so we sought molecules controlling super-enhancers," he added.

In the most recent publication by the Sakaguchi lab, which can be seen in Nature Immunology, Sakaguchi and his team report that Satb1 regulates the super enhancers essential for Treg cell development.

Looking at the Treg cell development pathway, the scientists found that the level of Satb1 was highest before Treg cells develop, and dropped after Treg cell development. Further study showed that Satb1 bound to the super enhancers responsible for Treg cell development, but again, only in progenitors that differentiated into Treg cells and not Treg cells themselves. Therefore, Satb1 may regulate the epigenetic changes that precede the creation of Treg cells.

"Satb1 appears to be necessary for the differentiation of Treg cells, but not for the maintenance of Treg cells," said Dr. Yohko Kitagawa, who first-authored the study.

Indeed, in mice lacking Satb1, the development of Treg cells was impaired and the mice showed symptoms of autoimmune disease. Furthermore, the progenitors cells of these mice showed inferior super enhancer activity, which resulted in less expression of the genes necessary for Treg cell development.

Based on these findings, Sakaguchi theorizes that defective Satb1-dependent super-enhancer establishment could be a cause of autoimmune diseases and allergy. "Autoimmune diseases are due to hyperactive immune systems. One cause is not having enough Treg . Understanding how this occurs is an important step towards treating autoimmune diseases," he said.

Explore further: Regulatory T cells' involvement in the progress of colon cancer

More information: Yohko Kitagawa et al. Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment, Nature Immunology (2016). DOI: 10.1038/ni.3646

Related Stories

Regulatory T cells' involvement in the progress of colon cancer

July 5, 2016
Researchers at Osaka University, clarified that T-lymphocytes expressing FOXP3 at a low level found in colorectal cancers (CRCs) facilitated cancer immunity. FOXP3 is a master gene of Regulatory T (Treg)  cells that suppress ...

Regulatory T cells decreased with farm exposure at age 6

October 18, 2016
(HealthDay)—At age 6 years, regulatory T cells (Tregs) are decreased with farm exposure and increased among those with asthma, according to a study published online Oct. 12 in Allergy.

A possible cure for allergies

September 8, 2015
Researchers discovered a mechanism that stops the body reacting with an excessive immune reaction. This could be the basis for a new treatment.

Controlling inflammation in fat cells to fight obesity-induced diabetes

March 27, 2015
The excess fat tissue associated with obesity causes inflammation and reduces glucose tolerance, which increases the risk of diabetes. The mechanism responsible for these physiological effects, however, has been unclear. ...

New insight into immune tolerance furthers understanding of autoimmune disease

September 15, 2011
It is no easy task to preserve the delicate balance that allows us to maintain a strong immune system that can defend us from harmful pathogens, but that is sensitive enough to correctly identify and spare our own cells. ...

Study exposes key requirement for regulatory T cell function

September 22, 2016
A Ludwig Cancer Research study published online September 5th in Nature Immunology illuminates a key requirement for the function of regulatory T cells—immune cells that play a critical role in many biological processes, ...

Recommended for you

Gene immunotherapy protects against multiple sclerosis in mice

September 21, 2017
A potent and long-lasting gene immunotherapy approach prevents and reverses symptoms of multiple sclerosis in mice, according to a study published September 21st in the journal Molecular Therapy. Multiple sclerosis is an ...

New academic study reveals true extent of the link between hard water and eczema

September 21, 2017
Hard water damages our protective skin barrier and could contribute to the development of eczema, a new study has shown.

Exposure to pet and pest allergens during infancy linked to reduced asthma risk

September 19, 2017
Children exposed to high indoor levels of pet or pest allergens during infancy have a lower risk of developing asthma by 7 years of age, new research supported by the National Institutes of Health reveals. The findings, published ...

Cholesterol-like molecules switch off the engine in cancer-targeting 'Natural Killer' cells

September 18, 2017
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as ...

MicroRNA helps cancer evade immune system

September 18, 2017
The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor ...

'Exciting' discovery on path to develop new type of vaccine to treat global viruses

September 15, 2017
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.